|
|
|
|
Breakthroughs in CAR-T are accelerating, but so are the complexities that come with them. As CAR-T advances, shifting clinical progress and market dynamics are reshaping development strategies. Explore how evolving therapies and operational demands are redefining the next wave of innovation.
|
|
|
|
|
Traditional sequential media development workflows often fail to surface manufacturability challenges until scale-up is underway. This session examines how AI-informed design, rapid prototyping, and early pilot-scale validation can reduce late-stage risk and support smoother transitions to cGMP manufacturing for complex biologics.
|
|
|
|
|
Chemically defined media are reshaping how E. coli systems are optimized. Understand the benefits of chemically defined media in E. coli systems, uncover real-world plasmid DNA data, and learn practical strategies for scaling to robust manufacturing.
|
|
|
|
|
Achieve faster timelines without sacrificing performance. Discover how this cell line development solution delivers highly productive pools in four weeks and clones in 14 weeks, with protein titers reaching ≥7 g/L while offering royalty-free licensing to reduce costs.
|
|
|
